107 related articles for article (PubMed ID: 17602832)
21. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T
Int J Cancer; 2003 May; 105(1):53-60. PubMed ID: 12672030
[TBL] [Abstract][Full Text] [Related]
22. Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity.
Augoff K; Grabowski K; Rabczynski J; Kolondra A; Tabola R; Sikorski AF
Cancer Invest; 2009 May; 27(4):443-52. PubMed ID: 19212830
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 counteracts effects of cyclosporin A on extracellular matrix metabolism by human dermal fibroblasts.
Abe M; Yokoyama Y; Syuto T; Ishibuchi H; Ishikawa O
Cell Tissue Res; 2008 Aug; 333(2):281-8. PubMed ID: 18553108
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta antisense oligonucleotides modulate expression of matrix metalloproteinases in isolated fibroblasts from radiated skin.
Riedel K; Kremer T; Ryssel H; Riedel F; Goessler UR; Koellensperger E; Germann G; Sauerbier M
In Vivo; 2008; 22(1):1-7. PubMed ID: 18396774
[TBL] [Abstract][Full Text] [Related]
25. Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release.
Kao YH; Jawan B; Goto S; Pan MC; Lin YC; Sun CK; Hsu LW; Tai MH; Cheng YF; Nakano T; Wang CS; Huang CJ; Chen CL
Cytokine; 2009 Jul; 47(1):11-22. PubMed ID: 19457680
[TBL] [Abstract][Full Text] [Related]
26. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
[TBL] [Abstract][Full Text] [Related]
27. Preferential increase of extracellular matrix expression relative to transforming growth factor beta1 in the pancreas during the early stage of acute hemorrhagic pancreatitis in rats.
Nakamura H; Tashiro M; Yamaguchi T; Asaumi H; Nomiyama Y; Watanabe S; Nagashio Y; Miyamoto T; Otsuki M
Pancreas; 2007 Nov; 35(4):e23-9. PubMed ID: 18090228
[TBL] [Abstract][Full Text] [Related]
28. Low concentrations of transforming growth factor-beta-1 induce tubulogenesis in cultured mammary epithelial cells.
Montesano R; Carrozzino F; Soulié P
BMC Dev Biol; 2007 Feb; 7():7. PubMed ID: 17288590
[TBL] [Abstract][Full Text] [Related]
29. Action of antiproteases on pancreatic cancer cells.
Uchima Y; Sawada T; Hirakawa K
JOP; 2007 Jul; 8(4 Suppl):479-87. PubMed ID: 17625304
[TBL] [Abstract][Full Text] [Related]
30. Sodium ascorbate (vitamin C) induces apoptosis in melanoma cells via the down-regulation of transferrin receptor dependent iron uptake.
Kang JS; Cho D; Kim YI; Hahm E; Kim YS; Jin SN; Kim HN; Kim D; Hur D; Park H; Hwang YI; Lee WJ
J Cell Physiol; 2005 Jul; 204(1):192-7. PubMed ID: 15672419
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
Nilsson UW; Jönsson JA; Dabrosin C
Exp Cell Res; 2009 Jan; 315(1):1-9. PubMed ID: 18996114
[TBL] [Abstract][Full Text] [Related]
32. Opposite effects of bFGF and TGF-beta on collagen metabolism by human periodontal ligament fibroblasts.
Silverio-Ruiz KG; Martinez AE; Garlet GP; Barbosa CF; Silva JS; Cicarelli RM; Valentini SR; Abi-Rached RS; Junior CR
Cytokine; 2007 Aug; 39(2):130-7. PubMed ID: 17728137
[TBL] [Abstract][Full Text] [Related]
33. [Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells].
Dong FQ; Li H; Wu F; Yao HP
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3444-7. PubMed ID: 19159581
[TBL] [Abstract][Full Text] [Related]
34. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
36. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.
Mauel S; Kruse B; Etschmann B; von der Schulenburg AG; Schaerig M; Stövesand K; Wilcken B; Sterner-Kock A
APMIS; 2007 Jun; 115(6):687-700. PubMed ID: 17550376
[TBL] [Abstract][Full Text] [Related]
37. Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro.
Lin JP; Yang JS; Wu CC; Lin SS; Hsieh WT; Lin ML; Yu FS; Yu CS; Chen GW; Chang YH; Chung JG
In Vivo; 2008; 22(2):223-30. PubMed ID: 18468407
[TBL] [Abstract][Full Text] [Related]
38. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
[TBL] [Abstract][Full Text] [Related]
40. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
Loo WT; Chen JP; Chow LW; Chou JW
Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
